REGENMED
Contract in vitro toxicity, genotoxicity and tissue-engineering testing for pharma, chemical and cosmetics companies
Highlights
- ProfitableFY2025 net profit €661 · RÚZ
About REGENMED
REGENMED spol. s r. o. is a Bratislava company founded in 2013 to link private-sector biomedical research with universities, specialised medical facilities and the Slovak Academy of Sciences. It works in regenerative medicine and stromal stem cell research.
Its commercial services include in vitro cytotoxicity and phototoxicity screening under ISO 10993, mutagenicity testing (Ames test, OECD 471), in vitro micronucleus tests (OECD 487), chromosomal aberration tests and the comet assay. It also develops and supplies custom tissue replacements, 3D tissue models, scaffolds and biopolymer carriers. Clients are pharmaceutical, chemical and cosmetics companies, and the services are sold on a contract basis.
Research is carried out with the Faculty of Medicine of Comenius University in Bratislava, the National Institute of Rheumatic Diseases and the Biomedical Center of the Slovak Academy of Sciences. The company has laboratories in Trnava, in addition to its Bratislava headquarters.
Product: Contract in vitro toxicity, genotoxicity and biocompatibility testing, custom tissue-engineering and 3D tissue model services, and regenerative-medicine research.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €45k | €85k | €352k | €21k | €76k |
| Growth | −47% | −76% | >+999% | −73% | — |
| EBITDA | €18k | €37k | €73k | €28k | −€23k |
| Operating profit | €1k | €5k | €38k | −€28k | −€73k |
| Net profit | €661 | €3k | €35k | −€32k | −€77k |
| Net margin | 1.5% | 3.7% | 10% | −152.9% | −100.8% |
| Personnel costs | €9k | €10k | €387k | €149k | €27k |
| Total assets | €158k | €162k | €266k | €344k | €293k |
| Cash | €88k | €41k | €37k | €136k | €7k |
| Liabilities | €46k | €51k | €157k | €271k | €188k |
| Equity | €112k | €112k | €109k | €73k | €105k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Jobs at REGENMED
Leadership
- Diana Oravcová · Konateľ (Managing director)Source: business register
More biotech & pharma companies
REGES
Pharmaceutical and medical device distribution from manufacturers to pharmacies and healthcare facilitiesYoung companyGrowingReKoMBe
Production and purification of recombinant proteins and peptides, DNA sequencing and lab solution consulting for biotech clientsYoung companyProfitableGrowingRoche Slovensko
Develops and supplies medicines and diagnostic solutions for patients and healthcare professionals in SlovakiaProfitableSanaClis
Contract research organization running clinical trials and clinical supply chains for pharma, biotech and device sponsorsProfitableSAVA PHARM
Italian-made linear hyaluronic acid joint injections for osteoarthritis, offered to clinics and institutionsYoung companySchwabe Slovakia
Markets plant-based medicines and dietary supplements to customers in SlovakiaProfitable
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.